Author Guidelines
Authors are invited to submit their manuscripts to the Journal of Biopharmaceutics and Clinical Pharmacy (JBCP) through the journal’s online submission system (OJS). Each submission undergoes an initial editorial screening to ensure alignment with the journal’s scope and basic quality standards. Suitable manuscripts are then forwarded for a double-blind peer review process. Based on reviewers’ feedback, the editorial decision may be acceptance, revision (minor or major), or rejection.
1. General Submission Requirements
- Manuscripts must be original, unpublished, and not under review elsewhere.
- All listed authors must have made significant contributions and approved the final manuscript.
- Authors are responsible for obtaining permission for any copyrighted or third-party material.
- Research involving humans, animals, or sensitive data must have appropriate ethical approval.
- The editorial team reserves the right to reject submissions that do not meet quality or scope requirements.
2. Manuscript Structure and Formatting
To maintain consistency and professionalism, authors must strictly follow the official journal template. Manuscripts not adhering to the required format will be returned for correction prior to peer review.
Manuscripts should include (where applicable):
- Title (clear and concise)
- Abstract (150–250 words)
- Keywords (5–10 relevant terms)
- Introduction
- Literature Review (if applicable)
- Methodology
- Results and Discussion
- Conclusion
- Acknowledgments (optional)
- Conflict of Interest Statement (mandatory)
- References (as per journal style)
3. File Format and Figures
- Manuscripts must be submitted in Microsoft Word format (.doc or .docx).
- Figures should be high quality (minimum 300 DPI resolution).
- Tables and charts should be editable whenever possible.
- Supplementary files (datasets, appendices, etc.) may be submitted separately.
4. Language and Presentation
Submissions must be written in clear and professional English. Authors should ensure grammatical accuracy and readability. Manuscripts requiring extensive language correction may be returned before review.
5. Plagiarism and Originality Policy
- All submissions are screened using plagiarism detection tools.
- The similarity index must not exceed 19%.
- Manuscripts exceeding this limit may be rejected or returned for revision.
- Self-plagiarism, duplicate submission, data fabrication, and falsification are strictly prohibited.
- Proper citation and referencing of all sources are mandatory.
6. Peer Review Process
Manuscripts passing initial screening are reviewed under a double-blind process. Reviewers assess originality, scientific quality, clarity, and relevance to the journal’s scope.
- Accept
- Minor Revision
- Major Revision
- Reject
Authors must respond to reviewer comments carefully and provide a clear revision report when resubmitting.
7. Post-Acceptance Process
- Accepted papers will undergo copyediting and formatting.
- Authors will review final proofs before publication.
- Articles are published under the journal’s open-access policy.
8. Publication Ethics
JBCP adheres to strict ethical standards in research and publishing. Any issues related to authorship, data integrity, or ethical misconduct will be investigated. The journal reserves the right to take appropriate actions, including article retraction if necessary.
9. Pre-Submission Checklist
- Does the manuscript follow the journal template?
- Is the work original and not submitted elsewhere?
- Have all authors approved the submission?
- Are permissions for third-party materials secured?
- Is the similarity index below 19%?
- Is ethical approval included where required?